Using the lowest dose that works reduces both side effects and treatment costs while maintaining benefits
But key details remain unclear, Dusetzina said
Its ability to enhance glucose-dependent insulin secretion while suppressing glucagon release makes it particularly relevant in models of type 2 diabetes and insulin resistance
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed for type 2 diabetes treatment, not cholesterol management
In 1 study of 16,122 women screened at a median of 47 days gestation, there were higher rates of major congenital anomalies (RR 2.67, 95% Cl 1.285.53), preeclampsia (RR 2.42, 95% Cl 1.285.53), shoulder dystocia (RR 2.47, 95% CI 1.055.85) and perinatal death (RR 3.96,95% Cl 1.5410.16) with an A1C of 5.9% to 6.4% in the first trimester (249)